K140857

Substantially Equivalent

INFLUENZA B LINEAGE GENOTYPING KIT, CDC HUMAN INFLUENZA VIRUS REAL-TIME RT-PCR DIAGNOSTIC PANEL

Applicant: Centers for Disease Control and Prevention
Product code: OZE
Advisory panel: Microbiology
Date received: 2014-04-03
Decision date: 2014-04-25
Decision: Substantially Equivalent
Clearance type: Special
Location: Atlanta, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.